Epilepsy Drugs Market Trends, Growth Opportunities and Global Outlook 2020-2025 – DPIResearch.com

DELHI, India - Nov. 14, 2020 - PRLog -- The proposed Epilepsy Drugs Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints & competitive landscape along with various micro & macro factors influencing the market dynamics.

Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives.

Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth.

However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.

Drug Leaders:

• Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It had a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period.
• Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021.
• It is expected that Lamictal will be the second leading drug with nearly XX% share by 2021.
• Onfi will hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.

"Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021" examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. The report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilepsy Drugs Market.

Key Epilepsy Drugs Covered in the Report are as follows:
1. Vimpat (Lacosamide)
2. Keppra (Levetiracetam)
3. Briviact (Brivaracetam)
4. Lamictal (Lamotrigine)
5. Neurontin (Gabapentin)
6. Depakine (Sodium Valproate)
7. Sabril (Vigabatrin)
8. Onfi (Clobazam)
9. Fycompa (Perampanel)
10. Inovelon/Banzel (Rufinamide)
11. Zonegran (Zonisamide)
12. Zebinix (Eslicarbazepine Acetate)

For More Information@ https://bit.ly/3oESUBL (https://dpiresearch.com/reports/epilepsy-drugs-market-glo...)